CBD Forum by Chow420

Go back
Refer
$20
Refer
Get $20 in Chowcash when you refer friends, stores, and brands to Chow420. Your friends also get $20 towards their first purchase when they accept your invitation.
Login to Refer

Hemp News, Laws & Product Updates

A curated news hub focused on hemp regulation and policy changes, cannabinoids (CBD/Delta-8/Delta-9/hemp-derived THC), lab testing and COAs, product safety, brands, and industry trends.

  • Federal & State Hemp Laws
  • THC Policy
  • CBD / Delta-8
  • Compliance
  • Lab Testing (COA)
  • Product Safety
  • Industry & Brands
Back to Chow420
https://hightimes.com/

Lawsuit Aims To Block Cops From Smoking Pot in New Jersey

If employees who drive buses, operate forklifts, and work with hazardous equipment aren’t allowed to test positive for pot should the police? After New Jersey’s Attorney General said that law enforcement officers can consume pot off-duty last year, a lawsuit aims to block officers on police forces from consuming cannabis, even off the clock. The New Jersey Monitor reports that Jersey City Public Safety Director James Shea, filed an 18-page complaint on Oct. 16, arguing that because federal law prohibits anyone who uses a controlled substance including cannabis from possessing a firearm, Jersey City cannot employ police officers who consume adult-use cannabis. Shea was joined in his announcement with Mayor Steven Fulop and Jersey City Police Department officials. The State of New Jersey, Matthew Platkin as Attorney General of the state of New Jersey, The New Jersey Civil Service Commission, Norhan Mansour, Omar Polanco, Mackenzie Reilly, Montavious Patten, and Richie Lopez are listed as the plaintiffs.  The lawsuit argues that federal law prohibits police officers from carrying ammunition, thus making them ineligible to be police officers. “The Federal Gun Control Act […] prohibits regular users of controlled dangerous substances, including marijuana/cannabis, from possessing or receiving firearms and ammunition,” the lawsuit reads.  “Police officers in New Jersey are required to possess and receive firearms in order to fulfill their duties as law enforcement officers. New Jersey legalized the regulated use of recreational marijuana/cannabis in New Jersey through passage of the Cannabis Regulatory, Enforcement Assistance, and Marketplace Modernization Act (CREAMM Act). In doing so, New Jersey failed to address the impact of the federal firearm laws on the use of regulated marijuana/cannabis in New Jersey for persons who are required to possess and/or receive firearms or ammunitions as part of the job duties, including police officers in Jersey City.”  The lawsuit clarified where specifically the law would need to be applied. “This action seeks a declaration pursuant to 28 U.S.C. § 2201, that the CREAMM Act and specifically N.J.S.A. 24:6I-52(a)(1) is preempted as it applies to adverse employment action to any individual who is an unlawful user of any controlled substance, including marijuana/cannabis, where such person is required to possess and/or receive a firearm or ammunition as part of his or her job duties.”  Shea defended his reasoning in challenging police officers’ eligibility based on testing positive for cannabis. “Every citizen in the state of New Jersey has the right to use marijuana,” Shea told the media at Jersey City’s public safety headquarters. ”If one of our officers wants to do that, they could smoke as much as they want—they can no longer perform the duties of a police officer, and we will have to terminate them if we become aware.” In April 2022, Attorney General Matt Platkin told law enforcement officials in New Jersey that state law requires them to allow officers to consume cannabis off-duty. This law was recently challenged in Jersey City: The state Civil Service Commission concluded that Jersey City must rehire a police officer who was fired after she tested positive for cannabis. At least three other officers fired for the same reason have also challenged their terminations, the New Jersey Monitor reports. The CREAMM Act was passed on December 27, 2020. The CREAMM Act authorizes the state’s Cannabis Regulatory Commission (CRC) to expand the existing Medicinal Cannabis Program, and develop, regulate, and enforce adult-use rules and activities. Shea added at the press conference that the CRC is “refusing to acknowledge the conflict between the federal law and the state law.” The lawsuit highlights the supremacy clause of the U.S. Constitution, banning states from overriding federal statutes. “We all agree that they smoked, they utilized marijuana, cannabis, or THC. We all agree that they would need to carry a firearm to be police officers,” he said. “So it should be as simple as a judge clarifying the supremacy clause.” Shea said the officers who were fired were all offered jobs in his department that did not involve guns, but the city refused to give them their old jobs back. He added that they were fired not because they used cannabis but because they can no longer carry a firearm, thus becoming ineligible to be police officers. The commission argued that there is no basis in the state’s adult-use cannabis law, the CREAMM Act, which allows employers to fire someone who uses cannabis outside of the scope of work on the clock, meaning Jersey City can’t fire officers who simply test positive for cannabis because they could have smoked weeks ago. The decision aligns with the Bureau of Alcohol, Tobacco, Firearms and Explosives, which said last March that people who consume cannabis are ineligible to possess firearms or ammunition under the federal Gun Control Act of 1968.

https://hightimes.com/

Vermont High Schools Float Getting Honest with Students About Legal Pot

You can’t ignore the elephant in the room—that is, that cannabis is now legal in Vermont and sold to adults, and it’s only a matter of time until high school students are fully aware of their future options when they become adults. WCAX in Vermont profiled various school officials to probe what their plans are and how the conversation around cannabis will continue, now that sales are legal for adults. “Acknowledging that marijuana laws have changed—it’s for sale—so we take a really nuanced view here, which is talking to them about the realities of situations, but also talking to them about where they’re at in their actual lives,” Matt Meunier, a student assistance programming counselor at Champlain Valley Union High School in Hinesburg, Vermont, told WCAX. Chittenden County—home to Champlain Valley Union High School—is also home to at least 10 cannabis retail stores, and school officials can’t keep pretending that they don’t exist. “Talking about decision-making, what choices you want and what life you want to live helps take it away from just, ‘Hey, this is all available to you now,’ to what type of member of my community do I want to be? What are my habits?” said Meunier. Meunier said there are more ways to consume cannabis now, but that there hasn’t been a noticeable increase in student use. “I think the longer that students put off using for the first time or experimenting for the first time, the easier it gets for them to make those choices and the healthier it will be for them at the end,” said Meunier. Kelly Dougherty with the Department of Health said that Vermont has the second-highest percentage of people nationwide aged 12 to 17 reporting using cannabis in the past 30 days—but that it’s ultimately up to parents to teach their kids about cannabis, among other things. The results of a Monitoring the Future (MTF) Survey, conducted by the University of Michigan, were released on Dec. 16, 2015 by the university and the National Institute on Drug Abuse (NIDA). The study revealed that daily cannabis use among high school seniors has “changed little since 2010,” despite the advent of legalization in several states and its consideration in many others. Another interpretation of the study, however, notes that cannabis use becoming more popular than tobacco use, because for the first time “more high school seniors smoke marijuana daily than cigarettes.” “Parents are the number one influence on their kids. Our kids are watching us all the time and they model the behavior that they see. So, even with alcohol, we recommend that if parents are using alcohol, keep it kind of out of sight and talk to your kids about the risks of it,” said Dougherty. The main concern appears to be curbing underage use until they are old enough to decide on their own. “We like to focus on helping youth develop healthy coping strategies, again, protecting brain health so they can be their best selves. Just because something is legal doesn’t mean it’s safe,” said Dougherty. On Jan. 22, 2018, Gov. Phil Scott signed the adult-use cannabis bill into law, which made Vermont the ninth state in the nation at the time to have legalized cannabis for both medical and recreational purposes. Starting July 1, 2018, adults living in Vermont were permitted to possess up to one ounce of cannabis, as well as grow up to six plants.  It would take over a year for retail sales to launch in the state. In 2020, Vermont became the 11th state to tax and regulate cannabis for adults. Two years later, sales figures are beginning to show the rewards. Adult-use cannabis sales officially launched in Vermont recently, with stores in three communities opening their doors to customers. Under Vermont law, a portion of the excise tax revenue is allocated to fill any deficit in the control board’s budget. Of the excise tax revenue, 70% goes to the state general fund, and 30% goes towards substance abuse and prevention funds. Cannabis sales tax revenue is earmarked for after-school and summer learning programs. Vermont’s adult-use cannabis industry took off with a bang. According to the Vermont Department of Taxes, Vermont cannabis stores sold $2.6 million worth of product in October, the first month of legal cannabis sales. James Pepper, chair of the Vermont Cannabis Control Board, said that $2.1 to $2.4 million in excise taxes could be collected during the first nine months of cannabis sales. That translates to around $233,000 to $267,000 per month. “They look pretty much like our projections were accurate,” Pepper said. Vermont legalized personal possession and cultivation of cannabis for adults back in 2018. The state legalized medical cannabis in 2004.

https://hightimes.com/

Study Finds Psilocybin Use Associated With Mental Health Benefits

A new study has found that using psilocybin outside of a clinical setting was associated with mental health benefits including decreases in anxiety and depression. The research, which was published last month in the journal Frontiers in Psychiatry, studied nearly 3,000 people who reported on their experience taking psilocybin mushrooms.  To conduct the study, which is reportedly the largest study of psilocybin in a naturalistic (non-clinical) setting, researchers spent two years collecting data from 2,833 participants who planned to take psilocybin for purposes of “self-exploration.” Most participants were college-educated white men in the United States who had previous experience taking psychedelic drugs. The study participants were asked to fill out five surveys as part of the research. The first survey was completed two weeks prior to the psilocybin experience, which usually consisted of ingesting dried mushrooms, and again the day before the planned psychedelic trip. The remaining surveys were taken one to three days after the experience, two to four weeks after and two to four months after taking the drug.  Not all of the participants who took the initial survey completed all five surveys, however. Of the nearly 2,833 participants who completed the initial survey two to four weeks before taking psilocybin, 1,182 completed the survey two to four weeks later, and 657 completed the final follow-up survey two to three months after their psilocybin experience. Upon analyzing the data from the surveys, the researchers determined that participants reported long-lasting reductions in anxiety, depression, alcohol misuse, neuroticism and burnout. Additionally, the participants reported improvements in cognitive flexibility, emotion regulation, spiritual well-being and extraversion. Not all of the study participants reported positive experiences, however. The researchers noted that a minority of subjects reported “persisting negative effects” following the psilocybin experience. Two to four weeks after taking psilocybin, 11% of survey respondents reported experiencing mood fluctuations and depression, while 7% reported such symptoms two to four months after the experience. Overall, the authors of the study reported generally positive experiences among the participants, leading them to call for further research into the potential mental health benefits of psilocybin therapy. “Though the findings reported here are generally positive in nature, questions remain about for whom such use may pose unnecessary risks, mechanisms underlying the persisting changes observed, and in what ways psilocybin’s unique profile of pharmacological effects may be optimally harnessed in clinical or other settings, presenting critical directions for future investigation,” the authors of the study wrote. Studies conducted by Johns Hopkins and other researchers have shown that psilocybin has the potential to be an effective treatment for several serious mental health conditions, including PTSD, major depressive disorder, anxiety and substance misuse disorders. A study published in 2020 in the peer-reviewed journal JAMA Psychiatry found that psilocybin-assisted psychotherapy was a quick-acting and effective treatment for a group of 24 participants with major depressive disorder. Separate research published in 2016 determined that psilocybin treatment produced substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer. Federal agencies including the Food and Drug Administration are currently reviewing the potential for psychedelics to treat serious mental health conditions. In May 2022, the head of the Substance Abuse and Mental Health Services Administration wrote to U.S. Representative Madeleine Dean, a Pennsylvania Democrat, that FDA approval of psilocybin to treat depression was likely within the next two years. As the nation faces rising rates of substance use and mental health issues “we must explore the potential of psychedelic-assisted therapies to address this crisis,” Miriam E. Delphin-Rittmon, assistant secretary for mental health and substance use, wrote to Dean. The ongoing research has prompted several states to consider legislation to ease the prohibition on psilocybin and other psychedelic drugs, particularly for therapeutic purposes. Last month, Oregon officials issued the state’s first license for a psychedelic therapy treatment center following the legalization of magic mushrooms for therapeutic use with the passage of a 2020 ballot measure. A similar initiative was approved by Colorado voters in 2022. California could be the next state to decriminalize psychedelics. Earlier this month, Governor Gavin Newsome vetoed a bill that would have decriminalized the possession and use of natural psychedelics including dimethyltryptamine (DMT), mescaline (except for peyote), and psilocybin and psilocin, the primary psychoactive ingredients in magic mushrooms, by adults aged 21 and older. Although he vetoed the measure, at the same time he called on state lawmakers “to send me legislation next year that includes therapeutic guidelines” for psychedelics. The new study, “Naturalistic psilocybin use is associated with persisting improvements in mental health and wellbeing: results from a prospective, longitudinal survey,” was published in September by the peer-reviewed journal Frontiers in Psychiatry.

https://hightimes.com/

Arizona Department of Revenue Release Cannabis Sales Data for June, July

The Arizona Department of Revenue recently released new data about cannabis sales reported for the months of June and July. Medical cannabis sales started in Arizona back in December 2012, while recreational cannabis sales started in Arizona in January 2021, but recent data shows that both industries have been experiencing a gradual decrease in sales. For medical cannabis during the month of June, sales dipped to $28 million followed by a downward trend of $26.1 million in July, which the Arizona Mirror reports as the lowest sales number for medical cannabis since recreational sales began. Within the past 30 months, medical cannabis sales have only fallen below the $30 million mark five times—all of which were recorded in 2023. This includes the months of January, February, May, June, and July, while sales in March and April remained above $30 million. The highest amount of medical cannabis sales that the state has collected in its history of sales was in April 2021 with $73.4 million, and other monthly sales data shows a decrease in sales, such as July 2022 with $40 million. These steady decreases in medical sales are seen alongside slight increases in recreational sales. In March 2023 recreational sales reached $99.9 million, while April recreational sales hit $90.1 million. However, June sales data shows a decrease to $85 million, followed by $77 million in July. The total amount of money collected from total cannabis sales in 2022 was $1.4 billion (medical brought in $500 million, and recreational hit $9.50 million). Since January 2021, the state has collected $1.5 billion in medical cannabis sales, while recreational sales made more than $2.2 billion within the same time period. Year-to-date data shows that so far between January-July, Arizona has collected a total of $207 million in medical cannabis sales, and $621 million in recreational cannabis sales. So far, the data reviews how recreational cannabis has reached new heights while medical cannabis sales gradually decrease, but both markets have been trending downward overall since March 2023. Data for state excise taxes show that recreational cannabis has generated more than $208.2 million in 2023 (so far), which is an increase compared to excise tax data for 2021. The department shows that adult-use cannabis generated $32.9 million over the course of 11 months, followed by $132.8 million in 2022. In overall cannabis excise taxes, Arizona has collected more than $360 million. State law requires that one third of cannabis excise taxes go toward community colleges, while 31% goes toward public safety as well as law enforcement and fire departments. Additionally, 25% is given to the Arizona Highway User Revenue Fund, which is distributed to various cities and towns to improve highway construction and other related expenses. Finally, 10% of cannabis taxes are put into the justice reinvestment fund, which can be used for various substance abuse programs, workforce development, but also to accomplish other goals such as helping residents expunge their criminal records. Cannabis patient card numbers are collected by the Arizona Department of Health Services, which recently reported that there were 126,938 cardholders in July, and 124,496 in August. The state’s highest number of cardholders was recorded in January 2021 with 299,054 patients. The department also shared that during the month of August, medical cannabis patients bought 4,719 pounds of various cannabis products. Between January and August, patients have purchased 37,979 pounds. Even though medical cannabis sales have decreased, it hasn’t stopped patients from using it to treat their various medical conditions. In March, a bill was introduced to add autism and post-traumatic stress disorder to the list of qualifying conditions, and was passed by the House in June. A year ago in 2022, more than 1,450 Arizonians were pardoned from their past federal cannabis possession convictions between 1992-2021, as directed by the Executive Order announced by President Joe Biden. According to Arizona attorney Jonathan Udell, this was a welcome change for people whose convictions have been on their record for decades. “I think there’s a lot of people out there that really feel the sting of being branded a non-law-abiding citizen,” Udell said. “And this sends a very big message to those people that you’re not a bad person because you smoked a plant one time that grew out of the ground or possessed some grass in your pocket.” While the industry keeps a close eye on the performance of both medical and recreational cannabis, other substances being researched for medical use are also continuing to grow. Earlier this year in May, an Arizona veteran was facing prison time for trying to treat his cluster headaches with DMT. “It’s the worst pain I’ve ever felt in my life,” Laetzsch said about the headaches. “Nothing helps the headache as well as DMT when I’m actually having it. It will abort the headache immediately. A small hit will abort the headache for about an hour to an hour and a half. If I take a bigger hit it can last longer but some of the headaches last a few hours so I would have to take a few hits during that episode. But, I would be pain-free. It wasn’t even a psychoactive amount that I smoked to abort the headache.” Currently, DMT is illegal in Arizona. Psilocybin is also illegal in the state, although recent legislation has been introduced to allow research to be conducted on the substance.

https://hightimes.com/

THC-M Cannabinoid: Everything You Need to Know

Lots of new cannabinoids have been popping up in the last few months, proving that the hemp market isn’t going anywhere.  With lots and lots of THC-based cannabinoids hitting the market one week after another, it’s easy for some to get lost in the mix.  But, one that you might want to keep an eye out for is THC-M, which is unlike any other cannabinoid we’ve talked about so far.   THCM may also be one of the least understood hemp derivatives so far, which means that it’s hard to talk about it in much detail, or even offer a clear picture of what kinds of effects it can offer.  However, what we do know shows a lot of promise, and may be something you really want to add to your cannabinoid rotation.  We’re going to examine THCM products to help hemp enthusiasts understand why this unique derivative really is a game changer that you may be missing out on without realizing it. You can also use the code HIGHTIMES25 for 25% off your order of THCM with fast and free shipping from Binoid. One of the best brands in the THC space. THC-M (Tetrahydrocannabinol Monomethylether) THC-M was first discovered in 1997, not as an isolated cannabinoid, but as a compound found in cannabis smoke.  It was used as a biomarker to identify possible in-utero exposure to cannabis, for up to 5 months before birth. THC-M has never been isolated, in fact, although we know that it is a naturally occurring, trace cannabinoid.   It’s actually a cannabinoid with zero research behind it, but it is determined to be a naturally degraded form of THC that results from aging plant material.  We also aren’t sure if it’s technically a metabolite of THC or not.  Of course, that hasn’t stopped hemp brands from using isomerization techniques to turn CBD into THC-M, through the rearranging of molecules, because what we do know about THC-M makes it worth creating for the general public of cannabinoid consumers. Naturally, the first question on most cannabis users’ minds is whether or not THC-M can get you high.  And, we actually don’t know. As of now, it doesn’t look promising. THC-M doesn’t seem to have any psychoactive capabilities according to the little we know about its chemical structure.  But, at the same time, if you’ve come across it on the market, you’ve seen it being sold in vape form. You’ll notice that vapes that contain THC-M also contain psychoactive cannabinoids like THC-P, delta 8, HHC, etc.  So, what is the THC-M actually contributing?  While THC-M is likely not psychoactive, it does seem to behave as a cannabinoid potentiator. What that means is taking THC-M with a psychoactive cannabinoid could potentiate – in other words, strengthen and enhance – the ‘high’.  Theoretically, then, combining, say, THC-M with THC-P would make THC-P more intoxicating, by enhancing its ability to bind to cannabinoid receptors and allow the full extent of its effects to be felt throughout the body and mind. Keep in mind again that THC-M is such a new cannabinoid that we can’t say for certain it doesn’t offer a high.  It’s just that it’s unlikely.  As more research is done, we hope to understand this property much better than we do now.  And, you won’t find any pure THC-M products on the market for now, which would allow you to test those effects for yourself, since demand just doesn’t exist at this point in time. So, what about specific benefits of THC-M, like effects related to pain, sleep, anxiety, etc.?  Again, we just don’t know. Without clinical research or extensive anecdotal information, we can’t really make any claims about THC-M’s benefits in a way that’s responsible. But, we can look at the potentiating nature of THC-M to get an idea.   Taking THC-M with a cannabinoid known for its benefits would, theoretically, enhance the benefits of the latter, so that’s something to keep in mind if you’re using hemp for therapeutic rather than recreational purposes. The laws surrounding cannabinoids can get tricky on a state level, but THC-M is completely legal according to federal law.  That’s because it complies with the 2018 Farm Bill, which states that all hemp products containing a maximum of 0.3% delta 9 THC are legal. THC-M is not delta 9 THC, and so there are no restrictions when it comes to how products can be sold. THC-M can exist in any concentration without any limitations. One thing to bear in mind is that 20 states have banned THC-M cannabinoids, and even though THC-M probably isn’t intoxicating, it is banned in: So, if you live in one of these 20 states, unfortunately, you can’t purchase THC-M at this time. Basically, for now, you’re only going to find mainly THC-M vapes, featuring cannabinoid blends.  We said before that it’s common to pair THC-M with intoxicating cannabinoids to offer a stronger high than you’d get from the cannabinoid alone.  Aside from vapes, you may come across the occasional gummy that features a cannabinoid blend containing THC-M. Overall, the same rules apply when shopping for THC-M as with any hemp product. Look for lab reports, and only buy from trusted brands with lots of great reviews. Right now, Binoid is working on THC-M products through their super popular cannabinoid blends line, so we recommend keeping an eye out, as Binoid is a highly trusted brand on the hemp market. THC-M is not a cannabinoid you’d necessarily try on its own, but it’s hard to resist the new products coming out that throw THC-M in with other cannabinoids we already know and love.  If you’re ready to give this potentiator a try, stick to a brand you can trust, already highly regarded for their super effective, top-quality products, like Binoid. This way, you’ll know you’re getting only a legitimate, clean, and lab-tested product that gives you the full potential of what THC-M can offer. And don’t forget to use the code HIGHTIMES25 for 25% off while being treated to fast shipping so that you can get acquainted with this fascinating cannabinoid in no time flat. To buy THC-M Cannabinoid Products Click Here

https://hightimes.com/

From Murder Capital to Vacation Destination: Exploring the New El Salvador

“You know who lives there?” Charlie, the man driving our boat, asks me as I jump into the deep blue water of Lake Coatepeque in northwestern El Salvador. He points to a minimalist-style villa on the freshly-mowed slopes of an island at the center of the lake. “That’s President Bukele’s. Ocho million dollares!” In any other Latin American country, people would talk about their leader’s private wealth with scorn. But Charlie’s tone is one of praise, excitement, even pride. It’s a sentiment I encountered again and again while traveling through El Salvador, and for a good reason. Until recently, the country was known and feared as the “murder capital” of planet Earth, with 1 in every 10,000 residents falling victim to homicide. Today, four years after Nayib Bukele assumed office, the number of annual killings has dropped from 5,000 to just 495: a statistic that has earned him the lifelong gratitude of his constituents. “I can finally go outside without worrying,” a student from Universidad Don Bosco in Soyapango, previously the most dangerous suburb in the capital city of San Salvador, told me. “It still doesn’t feel real.”  Born to a Muslim family that emigrated from Palestine, Bukele served as the mayor of San Salvador before setting his eyes on the presidency. A dark horse candidate, his anti-establishment, anti-corruption agenda allowed him to score a surprise victory against El Salvador’s entrenched elite. Many presidential candidates in Latin America promise to “drain the swamp” and put an end to the corruption that keeps their countries impoverished and oppressed, only to become a part of the establishment they vowed to tear down. Bukele is the rare example of a politician that not just kept his word, but managed to hold onto power while doing so.  One of Bukele’s top priorities was to hunt down El Salvador’s biggest gangs, Mara Salvatrucha (MS-13) and 18th Street, which earn money through prostitution, drug smuggling, human trafficking, and transporting aliens across the U.S.-Mexican border. The government’s pursuit of the gangs resembles less of a crackdown than it does an all-out war. To this day, tens of thousands of heavily-armed soldiers are regularly mobilized to besiege and infiltrate criminal strongholds.  Drastic problems require drastic measures, and Bukele’s was to arrest and imprison anybody who had even the slightest affiliation with the criminal underworld. As of 2023, more than 72,000 Salvadorians have been taken off the streets and stuffed into the country’s already overcrowded prisons.  Bukele’s policies on crime, while effective, come at a cost. While the state has managed to round up many dangerous offenders, it also detained a significant number of individuals who – after close examination – turned out to be completely innocent. Gabriela, a lifelong resident of San Salvador and tech entrepreneur I met at a Miami-esque beach party in the surfer town of El Tunco, told me how, one day, her private driver stopped answering his phone. After contacting his sister, she learned he had been taken by the police while standing on the street drinking Pilsner – El Salvador’s national beer – with former gang members. Accusing Bukele of human rights abuse, journalists and activists argue mass imprisonment won’t solve El Salvador’s problems but only make them worse. His proponents beg to differ: by cleaning up the streets, the president is able to develop public works that will improve the country’s economy and infrastructure. While highways and libraries can’t justify the injustice suffered by Gabriela’s driver, traveling through this new and improved, and above all, safer, version of El Salvador is making me kind of agree with the average citizen that these are, to an extent, necessary sacrifices. “I do not agree with everything Bukele does,” was the standard response I kept hearing from people, “but we are doing better than we were in the past – and that makes me feel hopeful about tomorrow.” Where so many corruption-stricken Latin American countries live in an inescapable present, El Salvador is able to look towards the future. In addition to his war on crime, Bukele is best known for his embracement of cryptocurrency. Shortly after setting up shop in San Salvador’s casa blanca, the 42-year-old leader surprised the world by investing a sizeable portion of government funding in Bitcoin. In hindsight, the decision wasn’t all that surprising. The crypto craze was at an all-time high back then, and with Bitcoin’s value on the rise, Bukele saw an opportunity and must have thought he was about to triple the country’s coffers, even quadruple the amount of money he’d put in. Unfortunately, his announcement came moments before the crash of FTX and the federal investigation of its CEO, Sam Bankman-Fried: events that set the crypto world on a downward spiral it has yet to escape from. While exact numbers are hard to come by, El Salvador is rumored to have lost upwards of $70 million. You’d think such a blunder would damage the country’s economy, not to mention Bukele’s credibility, but that does not seem to be the case. In contrast to neighboring Guatemala, where a despotic Attorney General is currently attempting to undo the ascension of a democratically elected, left-leaning president with an agenda not unlike that of his Salvadorian counterpart, El Salvador remains stable, peaceful, even prosperous. One of the biggest benefits of Bukele’s war on crime is that the resulting safety opened the country up to an industry that had hitherto been all but non-existent there: tourism. At Coatepeque, construction workers are building a litany of hotels, hostels, and clubs to accommodate growing numbers of travelers. Still more projects are in the works at Lake Llopango, located outside San Salvador.  “This place used to be extremely dangerous,” Gabriela told me as we walked up to a breathtaking mirador, or viewpoint, looking over a thick and seemingly endless canopy. “It’s where all the gangs from Soyapango went to hide.”  More confused than concerned, I glance over at two soldiers standing guard, their fingers on the triggers of their loaded shotguns. Laughing, Gabriela informs me that their presence is purely ceremonial: Bukele, needing to maintain the standing army he’s amassed for his war, sends troops across the country to act as glorified bodyguards. Not to protect visitors from kidnappers – those odds, she says, are low – but so they have something to do until they are called to lay siege to the next criminal hideout.  Though not as large as Guatemala and Honduras to the north, or as environmentally diverse as Nicaragua and Costa Rica to the south, El Salvador has much to offer the curious traveler. There’s Santa Ana, a colonial city near the Guatemalan border from where you can visit Coatepeque and climb the Santa Ana volcano, filled not with lava but with pools of boiling water. There’s El Tunco, the aforementioned surf town where you can test your skills on some of the largest, longest, roughest waves you’ve ever seen – or watch others do it from the beach.  Aside from the grueling traffic, San Salvador is a surprisingly organized capital where neon-lit hipster cafes share parking spaces with hole-in-the-wall pupuserias – barebone cafeterias serving El Salvador’s signature dish: thick tortillas made from corn or rice, stuffed with cheese, pumpkin, spinach, or chicharron, to name only a handful of ingredients.  While exploring El Salvador is no longer life-threatening, it’s still very adventurous. If you want to get from one place to another, you usually cannot book a private shuttle. Instead, you will have to hop on a public “chicken” bus, retired American school buses the U.S. government deemed too old and broken to transport children, but were given a second life in Central America. In many towns, you also have the opportunity to rent motorcycles. If you have never ridden one before, don’t worry – they neither require a license nor experience, and the roads of El Salvador are so chaotic that you’ll become a pro by the time you make it to your destination. That is, so long as you weren’t sent flying by some knee-deep pothole or camouflaged speed bump.  The biggest adrenaline rush (or panic attack) I had in El Salvador was a group tour of the Siete Cascadas or Seven Waterfalls near the town of Juayua, a 1 hour motorbike ride south of Santa Ana, where what I had expected to be a calm and peaceful stroll quickly turned into something out of the survival novel Robinson Crusoe. Walking barefoot through a jungle infested with spiders, snakes, and crabs – yes, crabs – I was so taken aback by the absurdity of my predicament that I didn’t even think to object when my tour guide (a 9-year-old, crab-catching boy called Cristian) told us to climb up the waterfalls rather than go around them. “I don’t think this tour was approved by the Salvadorian Health and Safety Department,” I half-joked, latching on to the slippery, moss-covered rocks and praying I would live another day.  As much as I ended up enjoying my stay, I originally didn’t plan on visiting El Salvador. Although I had heard of what Bukele was doing, I still pictured the country as it was in the past, the way it looked when I saw it on the news, or in an episode of World’s Toughest Prisons. Instead, I thought that I would spend more time in what the media portrayed as its safer, friendlier neighbor: Guatemala. Ironically, it was Guatemala that proved to be more unpredictable as, mere days after I entered El Salvador, rightfully-outraged Guatemalans clashed with law enforcement and barricaded the borders. Weeks later, they still haven’t managed to stop the old government from persecuting their president-elect. But that’s a different story. 

https://hightimes.com/

Former Tesla Employee Funds Multi-Million Dollar Harvard Psychedelic Program

Harvard will soon implement a new program of study dedicated to the use of psychedelics and how they impact various facets of the modern day, thanks to an eight-figure grant from a former Tesla employee. According to a news release, Harvard University will begin teaching a new multidisciplinary study of “Psychedelics in Society and Culture.” The course was funded by a $16 million grant from the Gracias Family Foundation, started by former Tesla employee and CEO of Valor Equity Partners, Antonio Gracias.  Gracias, a long time friend and colleague of Tesla CEO Elon Musk was a director at Tesla from 2007-2021. A Quartz article said  Gracias’ firm also served as an informal CEO of Twitter after Musk fired the original CEO immediately after acquiring the social media giant. The news release from Harvard said that the Gracias Family Foundation is interested in the potential of using psychedelics for therapeutic use as well as applying funding to such endeavors.  “Harvard is the ideal place to explore the topic of psychedelics from new angles, and to craft a framework for their legal, safe, and appropriate impact on society,” Gracias said in a statement. The news release from Harvard said that the new psychedelic-oriented program will be taught as a joint effort between the Faculty of Arts and Sciences, Harvard Law School, and Harvard Divinity School. The program will seek to apply Harvard’s record of excellence and professionalism to a topic often marred in mysticism and bro science partially leftover from the somewhat messy psychedelic and psychedelic-adjacent movements of the 1960’s. In Harvard’s own words, the program “seeks to transform the psychedelics research landscape by producing cutting-edge scholarship and convening faculty, students, and experts to engage in discussion around their far-reaching implications.” “We are thrilled to have the opportunity to bring students, faculty, and researchers together around the important issue of how psychedelics impact our society,” said Robin Kelsey, Shirley Carter Burden Professor of Photography and dean of arts and humanities. “Harvard is uniquely poised to become the most exciting place to debate, discuss, and innovate in this area.” The new Harvard program would not be considered the first psychedelic-based area of study at an American university as several psychedelic-based credential programs already exist at certain other colleges but this certainly marks a monumental announcement from an Ivy League University of Harvard’s caliber. The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School also started an initiative in 2021 called the Project on Psychedelic Law and Regulation (POPLAR) to study psychedelics’ “ethical legal and social implications.” The recent news was hailed by many as much-needed progress in the development of psychedelic education, including Michael Pollan, long-time psychedelic advocate and author of several books on the topic including “How to Change Your Mind” which was later made into a Netflix series.  “This is a visionary gift, in that it is the first to take the so-called psychedelic renaissance beyond medicine, by recognizing the importance of the humanities in exploring the impact and potential of these remarkable substances,” Pollan said in a written statement.  It was not immediately clear based on the news release specifically when the new program would be available to Harvard students or what sort of curriculum would be applied to a relatively new and still-emerging field of study. The news release did indicate that the program would “approach the field from a range of humanistic and social scientific viewpoints including law, policy, ethics, religion and spirituality, the nature of consciousness, and art and literature.” The news release also said that the $16 million from the Gracias Family Foundation would additionally be used to help fund  the expansion of existing programs at the Harvard Center for the Study of World Religions as well as funding new fellowships at the CSWR and the Mahindra Humanities Center.  “One of Harvard’s greatest strengths is our ability to bring together experts from various fields to engage in vibrant discussions that advance scholarship from multiple angles,” said Bruno Carvalho, interim director of the Mahindra Humanities Center. “This initiative will give us the space to explore and enrich public dialogue around psychedelics, including their potentials, as well as ethical and social implications.”

https://hightimes.com/

Paul McCartney-Signed Pot Arrest Cartoon Appears on Antiques Roadshow, Valued Up to $3,600

A cartoon depicting Paul McCartney being searched for pot by airport customs and with an autograph from the singer appeared on Antiques Roadshow season 46, episode 2 on Sunday, Oct., 5. The cartoon was valued between £2,000 – 3,000 ($2,437.12 – 3,655.71 USD). On the episode, Antiques Roadshow traveled to Crystal Palace Park in the heart of southeast London, revealing all sorts of treasures including a cigar once belonging to Winston Churchill and vintage Vivienne Westwood outfits. A guest arrived and said her father Pete was a cartoonist for over 30 years, and that one of his cartoons depicted Paul McCartney. The cartoon shows McCartney being searched by airport customs for pot in his luggage—drawn when The Beatles star and his late wife Linda were arrested for 10 grams of pot in 1984 in Barbados. It’s a single-frame cartoon similar to The Far Side. McCartney was apparently amused by it and signed the cartoon, pumping up the cartoon’s valuation dramatically. “Yesterday, all my troubles seemed so far away,” the cartoon reads. Pete drew McCartney being questioned by customs officials and singing sadly. The authorities emptied his luggage and placed what looks like a film canister and a little pile of weed on the table in the cartoon. There’s a newspaper on the floor that reads “Ex-Beatle Barbados Drug Sample…” At the bottom of the cartoon, it says “Play the pipes of peace”, a reference to “Pipes of Peace,” his No. 1 single on the UK Billboard at the time. “Yesterday” is one of 32 No. 1 songs composed or co-written by Paul McCartney—the most covered song of all time, according to Newsweek.  Antiques Roadshow antiques expert and frequent guest Hilary Kay was delighted by the cartoon of The Beatles star. “In turning it over, this is really nice, because it looks like a piece of HMRC notepaper, it’s got the reference there,” Kay said. “So while he was drawing this, Paul McCarney was being interviewed, and then, how come Paul McCartney has signed it?” The guest replied, “I think he just showed him the cartoon, that would have been my dad. He would have said ‘Hey, this is a bit of a tense moment, but this might make you laugh.’ “ Kay then said, “And Paul McCartney would have thought, ‘That’s just great’ and signed it off. How lovely, what a great story. Let’s cut to the chase, there was your dad sketching away, I wonder if he ever thought that it would be valuable?” The guest replied, “He wouldn’t have done, and I can tell you why—my dad hasn’t signed it. It will have been just a quick scribbly thing and I don’t think he would have valued it at all.” Kay said, “Well the market values it highly, because it’s a very interesting incident in McCartney’s career, and it’s too good a story. I think we’re talking about at least two to three thousand pounds. “And I hope that your dad would be really proud.” The daughter said, “I think he would, and I think he’d be proud that I’ve done this today.” You can watch the entire episode here. Inspiring the cartoon, McCartney and his late wife Linda were arrested for possession of 10 grams of pot in Barbados in January 1984 and fined $200 dollars—$100 each. McCartney was arrested frequently for pot, and I profiled his top five pot arrests in 2019, including this one. Undeterred, Linda was fined $105 on January 24—eight days later—on another cannabis charge. For the second charge, Linda was with McCartney at Heathrow Airport on their way back to the U.K. from their vacation in Barbados, and was carrying five grams of weed stuffed in a film canister that they apparently scored during the holiday.  This was nothing compared to his most serious arrest, though, four years earlier: On January 6, 1980, McCartney was caught with 218 grams (7.7 ounces) of “dynamite weed” into Japan at the Narita International Airport. He was locked up in a 4 x 8-foot cell in jail for nine days, and a spokesperson said that the Japan incident set McCartney back $420,000. While still in The Beatles, McCartney also paid the equivalent to a year’s worth of average wages to run an ad demanding that the U.K. legalize pot in a full-page ad to run in The London Times on July 24, 1967. The Beatles and band manager Brian Epstein joined a few dozen activists to urge lawmakers to legalize pot in the U.K. All four band members smoked and liked cannabis—but especially McCartney. “The law against pot is immoral and unworkable in practice,” the ad title reads. Pot is “the least harmful of pleasure-giving drugs, and […] in particular, far less harmful than alcohol.”  McCartney agreed to finance the full-page ad himself, and recruit the band to join in. Steve Abrams contacted Brian Epstein’s office, and shortly afterwards received a personal check from McCartney’s funds for £1,800 made out to The Times–the equivalent to £37,303.23 today, or $51,321.78, modified for inflation. McCartney said that 1966’s “Got to Get You into My Life,” was his first song officially about pot, though he tried it at least two years earlier. This cartoon pays homage to the artist’s troubles with pot.

https://hightimes.com/

Victorian Parliament Okays Medicinal Cannabis Driving Trial

The Victorian parliament has passed new laws that will allow medical cannabis users to get behind the wheel on a closed road. These new laws are part of a trial that will look into the impact marijuana has on a person’s driving ability. In 2016, Victoria was the first Australian state to legalize medical cannabis. However, individuals part of this program can still face legal consequences if they’re found to have tetrahydrocannabinol (THC) in their system while driving. The difficulty with this is THC can remain in a person’s system long after the “high” has worn out. That said, you can find yourself with an offense even if you haven’t consumed it for a few days. As of this time, Tasmania is the only state that allows for a medical defense if THC is found in a driver’s body fluids. This is the primary importance of Victoria’s trial – to determine what’s a safe level of THC to be driving with. Many Victorian medical marijuana users have raised concerns about the risk of losing their license or being fined. The Victoria parliament had initially addressed these concerns in 2021, but efforts were delayed due to COVID-19.  The government plans to commission an independent research organization (currently undetermined) which will be supported by the Department of Transport and Planning. And they’ve made sure to note that this research will take place in a controlled-driving environment that’s separated from public roads. Such efforts couldn’t come at a better time. According to road safety minister, Melissa Horne, the number of medical marijuana patients in Victoria has increased more than 700% over the last 2 years. While Victoria can recognize the many benefits medical cannabis provides to residents, there remain “significant gaps” in their understanding of THC. More specifically, how it affects drivers and what the risk is for road safety. “This bill will allow us to deliver a world-leading research trial into medical cannabis and driving, enhancing our understanding of how cannabis affects driving behaviour and informing future reform,” Horne said. There have been other efforts for reforms to road laws and medical marijuana. For example, upper house MPs Rachel Payne and David Ettershank, of the Legalise Cannabis party, have been championing for it to no longer be an offense if a driver who has detectable levels of THC in bodily fluid is unimpaired. Both Payne and Ettershank support the current trial but are concerned it will take too long. “The reality is patients continue to wait,” Payne said. “Medicinal cannabis has been prescribed since 2016, that’s a long time for patients to have to wait for a resolution.” She continued: “A medicinal cannabis patient should be treated like any other patient who is prescribed medicine by a doctor who also provides appropriate advice about when that patient is safe to drive.” Beyond this information, it would also help to have a way of testing impairment. Since law enforcement can’t resort to surefire results as seen with a blood-alcohol test, it would also benefit Victoria to determine a proper physical test to decide on a driver’s state of intoxication.

https://hightimes.com/

Eastern Band of Cherokee Indians Approves First Medical Cannabis Cards

The Eastern Band of Cherokee Indians (EBCI) is continuing its path toward cannabis accessibility, and as of last week the tribe officially issued its first medical cannabis cards. According to EBCI Cannabis Control Board (CCB) executive director, Neil Denman, a Cherokee Police Commission monthly meeting was held on Oct. 12. In a presentation featuring Denman and his colleague, Kym Parker, they stated that the first medical cannabis card was issued on that day, and many more will follow in the coming weeks. A total of 1,005 medical cannabis card applications were submitted, and so far 817 were approved. Only 129 are labeled as incomplete, due to missing assets such as a photo ID, and 59 were denied because of “lack of a qualifying ailment.” The EBCI live on a 57,000-acre reservation called the Qualla Boundary. The tribe’s website states that they have 14,000 registered tribe members, but the U.S. Census Bureau reports that the reservation is home to 9,600 people, 77% of whom are of Indian descent, and 23% non-Indian. The boundary is also home to two casinos that the tribe manages. The topic of transporting cannabis to its dispensary was called into question by Vice Chairman Joseph Buddy Johnson. For this to happen, the cannabis products must be moved on a state highway through Swain County. According to Denman, they are coordinating with Swain County to put together a transportation plan. The EBCI dispensary hasn’t opened yet, so the medical cannabis cards can’t be used. When the program becomes fully operational, the cards will limit how much daily and/or weekly cannabis that patients can purchase. Should a patient violate those rules, their card will be either suspended or revoked. The cards can also be used by off-boundary members who seek to grow their own cannabis plants at home. Currently there are plans for only one cultivation site at the moment, which is still under construction. In total, the grow will feature 42 hoop houses that will hold 2,040 plants. Eventually, they hope to expand their hoop house number to 69-70. Johnson inquired about plans for a second cultivation site, but Denman explained that the first site is the focus for now. Originally, the EBCI Tribal Council voted to decriminalize cannabis, as well as legalize medical cannabis back in 2021—a historic event considering that this was accomplished prior to the state of North Carolina making significant progress to legalize medical cannabis. By November 2022, EBCI had harvested its first cannabis crop. “It’s a vertical market. We have to plant it. We have to cultivate it. We have to harvest it. We have to process it. We have to package it and move through all of that network of product and get it there. It’s a lot of people,” said Qualla Enterprises LLC general manager, Forrest Parker. One month later, the EBCI Tribal Council agreed to provide Qualla Enterprises with $63 million to properly regulate medical cannabis. “This tribe, I’m so proud of us for putting us in a position to learn from other people’s mistakes so that when we do this right, that number is precise,” Parker said. “It’s not $150 million because we’re trying to cover all these things that we don’t know. We actually feel like we actually know.” In January 2023, the tribe announced that it would be moving forward with its plans to regulate medical cannabis on the reservation. The council voted to introduce their prepared regulations to the North Carolina General Assembly. Principal Chief Richard Sneed spoke at the meeting where the 12-person council approved the regulations, stating that it is of the utmost importance to keep the state legislature in the know. “All this is, is it as a matter of tribal law, before anybody does any work engaging with the state or federal legislature, we have to have permission of the governing legislative body to do so,” Sneed said. In another record decision on Sept. 7, the EBCI tribe members voted in favor of a proposal to permit the sale of recreational cannabis on tribal land as well. “The Council’s approval of a medical marijuana ordinance is a testament to the changing attitudes toward legal marijuana and a recognition of the growing body of evidence that supports cannabis as medicine, particularly for those with debilitating conditions like cancer and chronic pain,” said Sneed. Now the council will move forward with developing legislation to regulate legal cannabis. The Qualla Boundary is currently the only area of North Carolina where medical or recreational cannabis is legal. In July, Senate Bill 3 was introduced, which would have legalized medical cannabis for patients with life-ending illness. While the bill was initially passed in the Senate earlier this year, it didn’t receive support in the House. However, House Speaker Tim Moore announced that the bill was likely dead for 2023. In order for it to pass, it “would require a number of House members who’ve taken a position of ‘no’ to literally switch their position to want to vote for it, and I just don’t see that happening,” Moore explained.

https://hightimes.com/

Study: Legal Pot Retailers Not Linked To Rise In Crime

According to a study published this month in the Annals of Regional Science, the opening of a state-regulated cannabis dispensary “has no significant impact on local crime in the average neighborhood.” If you’re reading this, chances are you didn’t need to be told that –– but feel free to share with someone who does!  The researchers behind the study, affiliated with the University of Hawaii and Johns Hopkins University, examined data from the state of Washington, which joined Colorado in 2012 in becoming the first two states in the country to legalize recreational pot for adults. “Many North American jurisdictions have legalized the operation of recreational marijuana dispensaries. A common concern is that dispensaries may contribute to local crime. Identifying the effect of dispensaries on crime is confounded by the spatial endogeneity of dispensary locations,” the researchers wrote in the study’s abstract. “Washington State allocated dispensary licenses through a lottery, providing a natural experiment to estimate the causal effect of dispensaries on neighborhood-level crime. Combining lottery data with detailed geocoded crime data, we estimate that the presence of a dispensary has no significant impact on local crime in the average neighborhood. We estimate a small rise in property crime in low-income neighborhoods specifically,” they concluded. Previous studies have arrived at the same conclusion. One such study that was published in 2018 looked at “longitudinal data on local marijuana ordinances within California and thoroughly examining the extent to which counties that permit dispensaries experience changes in violent, property and marijuana use crimes using difference-in-difference methods.” “We find no significant impact of dispensaries on violent crime in any of our models,” the researchers wrote in their conclusion. “The consistency of findings regardless of inclusion or exclusion of the county-specific time trend is reassuring, but not surprising in light of the more consistent trends observed across counties in these measures.” They added: “The results suggest no relationship between county laws that legally permit dispensaries and reported violent crime. We find a negative and significant relationship between dispensary allowances and property crime rates, although event studies indicate these effects may be a result of pre-existing trends. These results are consistent with some recent studies suggesting that dispensaries help reduce crime by reducing vacant buildings and putting more security in these areas. We also find a positive association between dispensary allowances and DUI arrests, suggesting marijuana use increases in conjunction with impaired driving in counties that adopt these ordinances, but these results are also not corroborated by an event study analysis.” Another study, published in 2019, examined data out of Denver, Colorado, ultimately finding that the addition of a dispensary in certain neighborhoods led to a reduction in crime.  “The results imply that an additional dispensary in a neighborhood leads to a reduction of 17 crimes per month per 10,000 residents, which corresponds to roughly a 19 percent decline relative to the average crime rate over the sample period. Reductions in crime are highly localized, with no evidence of spillover benefits to adjacent neighborhoods. Analysis of detailed crime categories provides insights into the mechanisms underlying the reductions,” the researchers wrote. “We find that the overall effect of adding a dispensary to a neighborhood of 10,000 residents is a reduction of crime of around 17 crimes per month. In this section, we further analyze and decompose the data in order to provide a better sense of the underlying mechanisms that lead to crime reduction and to compare these findings with existing theories about the effect of legalization on crime…We use a novel identification strategy to show significant crime reductions in neighborhoods that receive marijuana dispensaries. To our knowledge, our research is the first research to use exogenous variation in dispensary locations to identify local crime effects of marijuana dispensaries. We find that adding a dispensary to a neighborhood (of 10,000 residents) decreases changes in crime by 19 percent relative to the average monthly crime rate in a census tract,” they added. Somebody ought to pass these findings along to Republicans on Capitol Hill. Last year, GOP members of the House of Representatives unveiled its “Family Policy Agenda” that emphatically opposed marijuana legalization, contending that ending the prohibition on pot will lead to a spike in violent crime and suicide. Yes, seriously. “Marijuana remains a federally scheduled controlled substance, but that has not stopped more and more states and localities from legalizing it under their own laws,” the agenda read. “Congress should not legalize marijuana, while also taking steps to constrain this new industry’s ability to harm children. At the very least, Congress should direct the CDC to gather data and conduct studies on the health impacts of THC use during childhood and early adolescence with a special focus on deaths by suicide and those involved in violent crime to provide Congress and the public with further information about these dangers.”

https://hightimes.com/

Study: LSD Use On the Rise Among American Business Leaders

A recent analysis of psychedelic drug use among American adults has indicated that business leaders and managers seem to be dropping more acid than their subordinates.  The study, published last Wednesday in the peer-reviewed journal Substance Use and Misuse, analyzed data from the National Survey on Drug Use and Health and looked at trends related to use of lysergic acid diethylamide, commonly known as “LSD,” or “acid.” The study looked at data from over 168,000 adults over the course of the years 2006-2014 and found that people who identified themselves as managers in their field had experienced a notable increase in LSD use in the last year of the study, significantly more so than other full-time employees who did not identify as managers.  “The results suggest that the prevalence of past year LSD use increased over time at a greater rate among business managers than non-managers and that this difference cannot be accounted for by changes in business managers’ perceived risk of LSD use or general substance use relative to non-managers,” the study said.  NSDUH survey responders self-reported their own drug use which included information on psychedelics including LSD. Researchers used this information to form correlations and they found that business managers and leaders experienced a .07% increase in LSD use over the last year of the study whereas other full time employees who were not in a leadership position only increased by .02%. Author of the study and postdoctoral researcher at Germany’s University of Bamberg, Benjamin Korman, told PsyPost that he wanted to embark on this study in order to apply science and logic to a recent resurgence in popularity with regard to classical psychedelic use among American adults. “The number of anecdotal media reports on psychedelic drug use among employees and business leaders have increased dramatically in recent years, though empirical evidence regarding the prevalence of this use was lacking,” Korman said to PsyPost. “My intent was to determine whether these media reports stemmed from skewed reporting or were representative of an actual shift in psychedelic use within the workplace.” Indeed psychedelic use has been on the rise once more, in part due to a new swath of studies and academic interest in the use of psychedelics to treat a barrage of treatment-resistant mental health disorders. In terms of recreational use, the majority of psychedelic use has long been associated with a younger demographic. This is likely the lingering sentiment of Nixon-era propaganda portraying psychedelic users as degenerates and draft-dodgers.  However, the data does reflect that young adults are by far the biggest consumer demographic of psychedelic drugs, although a 2022 study by the Columbia University Mailman School of Public Health found psychedelic use was actually decreasing among adolescents. However, Korman told the PsyPost he wanted to identify trends outside of age-related correlations.  “Although previous research has suggested that psychedelic drug use in the United States is predominantly increasing among young adults, my findings suggest that notable growth in use is also to be found among those at the highest tiers of organizational hierarchies,” Korman said to PsyPost. This data represents a major shift in LSD use, according to the study, as in 2006 LSD use was higher among subordinates than among higher ranking members of company hierarchies. In 2014, managerial LSD use increased at a higher rate than regular employees. This could be due to a myriad of factors including public perception shift with regard to the risks of taking psychedelics that may have made it easier for certain people to try them. However, Korman told PsyPost that his team accounted for several different factors over the course of the study and could not identify a direct causal relationship between risk association and LSD use. Rather, he said the opposite could be true.  “I was surprised that decreasing perceptions of the risks associated with LSD use could not explain the findings,” Korman said. “This suggests that it is not the potential negative effects of LSD that are responsible for differences in use between business managers and non-managers, but maybe perceptions of the potential positive effects of LSD use.” These findings are, naturally, preliminary and subject to more review. It is important to note that the study could not provide any insight on current day LSD trends as the available data stopped in 2014. More research will need to be performed to dispute or verify Korman’s claims and figure out specifically if/why managers might be celebrating Bicycle Day more than their employees.  “In line with my previous comment, one question that remains unanswered is why the prevalence of LSD use among business managers increased,” Korman said to PsyPost. “My study could only show what wasn’t explaining the effect, but not what is.”

https://hightimes.com/

McCormick Sues Cannabis Company Over Parody Sticker

Annapolis, Maryland-based cannabis company Crabcakes & Cannabis®, pulled a popular parody sticker after receiving a cease-and-desist letter from McCormick & Company, Incorporated, the makers of Old Bay® seasoning, who said their sticker was too similar to their Old Bay logo.  Crabcakes & Cannabis took the opportunity to challenge the implications of a Supreme Court decision last June that is impacting all types of small businesses. The issue brings up the question that if parodies aren’t allowed, are we taking trademark laws too far? The novelty sticker parodies the Old Bay spice jar, but it ended up prompting a lawsuit as McCormick alleges a trademark infringement and tarnishing of their image by associating it with cannabis. “While we firmly believe in the protection of parody and First Amendment rights, the prohibitive cost of litigation led us to make the difficult decision to discontinue our parody sticker,” Founder of Crabcakes & Cannabis Jennifer Culpepper said in a statement We stand by the fact that no reasonable consumer would confuse our novelty item with a food seasoning product.” The cease and desist letter sent from McCormick & Company claims that the parody sticker, featuring the words “420 BUD” and designed in a way that’s reminiscent of the Old Bay jar, infringed upon their trademark and trade dress, potentially harming their brand’s reputation.  Per the letter, McCormick stated that the company “takes this matter very seriously, as it is not in the business of sponsoring products relating to marijuana use.” Culpepper continued, “We deeply respect businesses’ (and artists’) rights to safeguard their brands, but it is paramount that we strike a balance between these rights and the freedom of expression and creativity that parody affords. When a large business bullies a small business through costly litigation, it makes standing up for your rights nearly impossible. Regardless, we still love Old Bay. Our parody sticker was intended to pay homage to the Maryland brand, not to tarnish anyone’s reputation.” Culpepper also owns Brand Joint, a national branding agency, and she has been on the other side of a copyright infringement case in the past. She stated, “We have always been very careful not to copy, but rather to create fun and unique parody designs that celebrate Maryland icons.” The company hopes something good can come out of the incident for the better. Culpepper concluded, “We hope that this experience will spark a broader conversation about the importance of protecting parody and freedom of expression in our society. Last June, a dog toy company Bad Spaniels triggered a lawsuit saying that the company copied elements of Jack Daniels that violated trademark laws. Jack Daniel’s Properties v. VIP Products rejected the use of images that resemble Jack Daniel’s trademarks by a manufacturer selling a line of dog toys that mock various beverage manufacturers. Justice Elena Kagan said there were four main elements used by Bad Spaniels that violated trademark laws: All members of the court agreed with Justice Kagan’s opinion to deem that toy a condemnable infringement of the Jack Daniel’s marks. A number of other cannabis companies have faced similar lawsuits—particularly cannabis products that mimic or parody major candy brands. Skittles maker Mars Wrigley won a lawsuit in August 2022 against cannabis companies that mimicked the candy. Mars initially filed the lawsuit in May 2021, claiming that the illegal retailers infringed on Mars’s registered trademarks.  Mars Canada Inc., global candy giant and Mars Wrigley, which oversees confections such as of M&M’S®, SNICKERS®, ORBIT®, EXTRA® and Skittles®, recently concluded a lawsuit involving the use of the Skittles logo on illegal cannabis products. On Aug. 12, a federal Judge Patrick Gleeson ruled that three online cannabis retailers “deliver up and destroy all infringing products and packaging,” and also pay various sums for infringing upon Mars’s trademark. In August 2017, the Ohio-based glue company that produces Gorilla Glue took GG Strains to court due to the use of “Gorilla Glue” in numerous strain names. In February 2018, the company went after cannabis companies who were infringing upon the Hershey’s Chocolate trademarked products. In February 2019, a group of delivery businesses called United Pot Smokers, UPS420, and THCPlant, were brought to court by UPS (United Parcel Service) regarding misleading brand identifiers. Later in July 2019, Sour Patch Kids candy maker targeted an illegal cannabis edibles product called “Stoney Patch” for infringing upon the trademark.

https://hightimes.com/

Court Order Allows Maryland Shops To Resume Sales of Intoxicating Hemp Products

A Maryland judge has temporarily suspended portions of the state’s marijuana legalization statute prohibiting the sale of hemp-derived products with intoxicating cannabinoids. The judge’s order allows hemp and CBD shops to resume selling the products while a lawsuit challenging the state’s cannabis legalization law continues.  The legal action was filed in July by a group of business owners and the Maryland Hemp Coalition challenging provisions of the state’s marijuana legalization law that only allow businesses approved by state cannabis regulators to sell products that contain THC. The law also restricts sales of other intoxicating cannabinoids derived from hemp, including delta-8 THC and delta-10 THC, which have been sold in Maryland by hemp businesses for years following the legalization of hemp with the 2018 Farm Bill.  The named defendants in the case are state Governor Wes Moore, the Maryland Cannabis Administration and the Maryland Alcohol, Tobacco, and Cannabis Commission. Attorneys for the defendants have filed motions to dismiss the lawsuit but have not succeeded. The plaintiffs argue in the suit that the law wrongfully requires them to either obtain a cannabis business license, which is subject to eligibility requirements, stop selling products they have been selling for years, or close their businesses. The plaintiffs allege that the law violates the Maryland Constitution’s equal protection and anti-monopoly clauses by excluding them from the state’s regulated cannabis market.  In an order handed down on Thursday, Washington County Circuit Court Judge Brett R. Wilson said the restrictions on hemp products with intoxicating hemp products would “irreparably harm” the plaintiffs, some of whom have had to close their businesses selling hemp-derived cannabinoid products. Wilson said his order “is not contrary to the public interest.” The order allows the plaintiffs to temporarily resume selling products with hemp-derived cannabinoids while the lawsuit continues. After Wilson handed down the order, state officials said it would hurt efforts to make products containing THC, including hemp-derived THC, safe for consumers. “The Administration was disappointed to learn of the preliminary decision in Washington County Circuit Court allowing for the continued sale of unregulated, untested, and intoxicating hemp-derived products,” William Tilburg, the director of the Maryland Cannabis Administration, said in a statement from the agency. Leaders in the state legislature also expressed dissatisfaction with the judge’s order and predicted that the lawsuit would not prevail. “We are disappointed in the Washington County Circuit Court’s initial order regarding Maryland’s landmark recreational adult-use cannabis legislation,” House Speaker Adrienne A. Jones and Senate President Bill Ferguson said in a joint statement. “We remain confident that the law is legal.” The judge’s order was welcomed by the plaintiffs including business owners who had temporarily closed their shops to comply with Maryland’s cannabis legalization statute. “We’re happy that, for now, we’re back in business,” said Nevin Young, the plaintiffs’ attorney. “This is really about the state wanting sole control — through a very limited number of retailers — of the market for all THC products,” he added. Young said that the plaintiffs had provided evidence in court to show that the products they sell do not pose a risk to consumers, a claim frequently made by the state’s cannabis regulators. “They brought products to the hearing with them that are tested in independent laboratories that actually exceed the standards that the state of Maryland requires for the products sold in the state,” he said. “They have basically been shut out. Not because their products are dangerous, but because their products are undesired,” Young added. Nicholas Patrick, one of the plaintiffs in the case, said that he had to close his three Embrace Wellness Centers because of the restrictions. Together, the three shops were the heart of a business that generated more than $1.5 million per year and employed several workers. “I was inches away from bankruptcy,” Patrick told the Washington Post on Thursday before a coalition of plaintiffs met to discuss their next steps. “Hopefully, I can get my business up and running and take care of my family.” Patrick said that revenue at his business declined by 74% after Maryland’s cannabis legalization statute went into effect. He was eventually able to convert one of his locations to a smoke shop, but he has had to permanently close the other two retail operations and he was forced to lay off four employees. “The human cost for me was the worst cost,” Patrick said. “We had to let them go, and it broke my heart in a million pieces. … I don’t even have the financial means to get them back opened up. I have no money left.”

https://hightimes.com/

Ohio Senate President Plans To Repeal Cannabis Legalization if Passed by Voters in November

The official voting day for Ohioans is Nov. 7, but early voting has already begun on Oct. 11. This is a significant year for cannabis because a cannabis legalization measure, which is labeled as Issue 2, is appearing on the ballot. However, some legislators are not thrilled with the idea that cannabis legalization could be approved, and announced plans to possibly repeal the law if it does get passed. Senate President Matt Huffman spoke on the Senate floor in opposition of SR-216, stating that it will be “coming right back before this body” and will likely receive changes. “We’re going to have a mental health crisis on our hands,” Huffman said, if voters approve Issue 2. “We are going to pay for this for years and years and years, and it’s only going to get worse.” He added that he will push to review and repeal parts of the bill if it gets passed. “If Issue 2 passes, there will be more teenagers in the state of Ohio committing suicide,” Huffman said. “And our reaction to that will not be, ‘Let’s make marijuana illegal,’ because by that time, more people will be making lots of money. It will be, ‘Maybe we should hire drug counselors, get into the schools, talk about kids not taking drugs.’ But by then it will be too late. It’ll be even more part of our culture. And no, I’m not a scientist, but I’m a person who can look at facts and listen to scientists and know that that’s true.” Just as early voting began last week, Republican Sen. Mark Romanchuk and Rep. Terry Johnson, along with 14 other cosponsors, introduced Senate Resolution 216, claiming all of the potential harms that legalization will bring if voters choose to vote and approve Issue 2. “…The proposed statute authored by the commercial marijuana industry does not serve the best interests of the people of Ohio, will bring unacceptable threats and risks to the health of all Ohioans, especially children, will create dangers in the workplace and unacceptable challenges and costs to employers, will make Ohio’s roads more dangerous, will impose significant new, unfunded costs to Ohio’s public social services, and serves only to advance the financial interests of the commercial marijuana industry and its investors…,” the bill text stated. Many of the points of concern in the bill have long been used by anti-cannabis supporters, such as calling cannabis a gateway drug that leads four of our 10 people to try other drugs, and that cannabis use leads to opioid use disorder. While it claims that drug overdoses are the “leading cause of injury and death” in the state, with an estimated 33,000 Ohioans having died due to drug overdoses between 2011-2020, state records for COVID-19 deaths are recorded at over 42,000.  The Center for Disease Control and Prevention shows that the top 10 leading causes of death in 2017 for Ohioans was heart disease, cancer, accidents, chronic lower respiratory disease, stroke, Alzheimer’s disease, diabetes, flu/pneumonia, kidney disease, and septicemia. The resolution also included claims that regular cannabis use “can irreversibly reduce intelligence, memory, and learning ability,” along with claims that underage cannabis use causes risks of academic performance, IQ, and behavior, and that cannabis in adolescence leads to risks of “psychosis, a severe mental disorder characterized by distorted thinking and loss of touch with reality, as well as depression and suicide.” They conclude the bill text by stating that they urge voters to reject Issue 2 to “preserve and protect our state’s high quality of life, the health and safety of our citizens, the strength and prosperity of our communities, our strong economic growth, our favorable environment for business success, and opportunity for all citizens and the future for our young people…” The campaign group submitted nearly 130,000 signatures to get Issue 2 onto the ballot, after first coming up short of the necessary 124,046. “It looks like we came up a little short in this first phase, but now we have 10 days to find just 679 voters to sign a supplemental petition—this is going to be easy, because a majority of Ohioans support our proposal to regulate and tax adult use marijuana,” said Coalition to Regulate Marijuana Like Alcohol (CRMA) spokesperson Tom Haren. A recent poll from the CRMA, which is the same advocates group behind the initiative, found that three out of every five Ohioans plan to support the measure come November. A similar poll conducted in September 2020 showed that voters said they were “29% “strongly approving” and 34% “somewhat approving” (63% total) compared to this year’s results with “50% strongly approving” and “17% somewhat approving” (67% total). Recent projections from Ohio State University show that the state could generate somewhere between $275 million to $403 million in recreational tax revenue by the fifth year of legalization.

https://hightimes.com/

New Study Reveals Potential Benefits of Cannabis for COVID-19 Patients

Years now after the height of the pandemic, a new study shows evidence of the benefits of cannabis for those who had COVID-19. According to the researcher’s conclusions, cannabis consumers affected by COVID-19 experienced “better outcomes and mortality” compared to non-consumers. The study, entitled “Exploring the Relationship Between Marijuana Smoking and Covid-19,” was announced at a meeting for the American College of Chest Physicians, which was held in Honolulu, Hawaii on Oct. 11. It was also published in the October issue of CHEST Journal. Researchers noted that they analyzed data from the National Inpatient Sample, which is the largest publicly available collection of inpatient healthcare data—recording about seven million hospital visits per year. Researchers studied 322,214 patients over 18 years of age, with only 2,603 stating that they were cannabis consumers. Each cannabis-consuming patient was matched 1:1 with a non-consumer, as well as their “age, race, gender, and 17 other comorbidities including chronic lung disease.” The other comorbidities included obstructive sleep apnea, obesity, hypertension, and diabetes mellitus, which were more commonly found in non-users. In these comparisons, cannabis users experienced a lowered rate of specific conditions. “On univariate analysis, marijuana users had significantly lower rates of intubation (6.8% vs 12%), acute respiratory distress syndrome (ARDS) (2.1% vs 6%), acute respiratory failure (25% vs 52.9%) and severe sepsis with multiorgan failure (5.8% vs 12%),” researchers explained. “They also had lower in-hospital cardiac arrest (1.2% vs 2.7%) and mortality (2.9% vs 13.5%).” “Marijuana smokers had better outcomes and mortality compared to non-users,” researchers concluded. “The beneficial effect of marijuana use may be attributed to its potential to inhibit viral entry into cells and prevent the release of proinflammatory cytokines, thus mitigating cytokine release syndrome.” These findings led researchers to add a note about these results, and the potential clinical implications. “The significant decrease in mortality and complications warrants further investigation of the association between marijuana use and COVID-19,” researchers added. “Our study highlights a topic of future research for larger trials especially considering the widespread use of marijuana.” After the pandemic began, researchers’ inability to study cannabis freely as a way to help people suffering from COVID-19 became immediately apparent, due to the Schedule I status of cannabis. In July 2020, Dr. Laszlo Mechtler, Medical Director of the Dent Neurological Institute in Buffalo, New York, explained the need to reclassify cannabis. “It is my opinion that much of this lack of understanding stems from the lack of research that has been done on cannabis, which is rooted in marijuana’s classification as a Schedule I controlled substance by the federal government,” Mechtler said. That same month, researchers at the University of Nebraska and Texas Biomedical Research Institute began a study to analyze how CBD could help treat deadly lung inflammation that’s often associated with COVID-19. In July 2022, High Times interviewed Professor Richard Van Breeman from Oregon State’s College of Pharmacy and Linus Pauling Institute Global Hemp Innovation Center. Breeman shared about his research, which was initially published in January 2022, in relation to cannabis and its effects on SARS-CoV-2, which is the cause of COVID-19. “Our team discovered that cannabidiolic acid (CBDA) and cannabigerolic acid (CBGA) can bind to the spike protein of SARS-CoV-2. We also discovered that these compounds can block cell entry using live SARS-CoV-2,” Breemen said. “That means cell entry inhibitors, like the acids from hemp, could be used to prevent SARS-CoV-2 infection and also to shorten infections by preventing virus particles from infecting human cells.” Another study published in August 2022 found that cannabis consumers experienced less severe COVID-19 symptoms, and improved clinical outcomes. “Consistent with known trends, active cannabis users were overall younger than non-users,” researchers wrote. “However, when adjusting for age these outcomes remained consistent. Even more, when adjusting for comorbid conditions, demographics and smoking history we found that cannabis users still had less severe disease progression compared to non-users.” In that particular study, researchers reviewed the cases of 1,831 COVID-19 patients who required hospital admission. “While there was a trend toward improved survival in cannabis users, this was not statistically significant,” researchers explained. “To our knowledge, this is the first study looking at clinical outcomes of cannabis users hospitalized with COVID-19. Further studies, including prospective analyses, will help to better understand the relationship between cannabis and COVID-19 outcomes.” In September 2022, cannabis was used by many to treat the symptoms of long COVID, although there is little research to support its efficacy. “It helps keep me focused or at least my mind off negative thoughts brought on by long COVID,” David, a patient and long COVID sufferer told High Times. For me, but much more so for my partner, it helps settle nausea. My partner literally wouldn’t be able to hold down the first meal of the day for a time without taking an edible to help settle their stomach. And sleep, oh do I enjoy actually getting to sleep again since becoming a heavier cannabis user.”

https://hightimes.com/

Colorado Has Sold Over $15B in Cannabis Since Legalization

The Colorado Department of Revenue (DOR) released a monthly cannabis sales report for August, the latest month available, showing that adult-use and medical cannabis sales surpassed $15 billion. While the overall picture looks good, sales are actually down during the past few years since peaking during the pandemic, and the downward trend worries some analysts. The data shows Colorado adult-use and medical cannabis sales reached a total of $15,028,995,376. Since 2016, the state has sold $1-2 billion in cannabis each year. But because of oversupply issues ultimately leading to lower prices, Colorado sales are expected to be lower in 2023 than prior years. The DOR’s Marijuana Sales Reports summarize total sales made by medical and retail cannabis stores monthly by county. The Marijuana Sales Report has monthly total sales for the state, and the Marijuana Sales by County Report shows monthly sales by medical and adult-use cannabis stores by county. Adult-use cannabis sales launched in Colorado in January 2014.  Sales are still up compared to when the market launched in 2014, but has fallen precipitously since its peak during the pandemic. The Colorado cannabis market sold almost $2.2 billion in 2020 and more than $2.2 billion in 2021, as many residents  were forced to quarantine at home, and government stimulus checks provided people with some extra cash. That’s because the state’s dispensaries are struggling amid an economic downturn. Sales of both medical and adult-use cannabis in Colorado plummeted in June 2022—marking a downward trend that extends to today. Unless cannabis sales pick up in Q3 of 2023, full-year cannabis sales could be down from 2022, when Colorado cannabis companies sold $1.7 billion in cannabis, matching sales in 2019. As of the end of August, year-to-date sales tallied in at just over $1 billion. In Colorado’s largest city and capital, and the corresponding county, the drop in sales is acute. A July report from the City and County of Denver shows a 22% decline in annual cannabis sales revenue from 2021 to 2022, the largest annual drop since legalization launched. Consumers who are strapped for cash are buying fewer expensive products, Truman Bradley with the Marijuana Industry Group told 9 News. “The ripple effect to employees and customers can’t be overstated either,” he said. “As cannabis sales drop, so do the tax revenues.”  Denver makes up about a third of the state’s entire cannabis sales. “In 2021, 31% of Colorado’s total marijuana sales occurred in the City and County of Denver,” a Municipal Marijuana Management report from 2022 reads. “From 2014 to 2021, the proportion of marijuana sales in Denver out of all Colorado marijuana sales has fallen by 17%, going from 48% to 31%. This downward trend, which has been consistent since the implementation of retail marijuana sales in 2014, indicates marijuana sales growth outside of the City and County of Denver has been increasing faster than within the city.” A recent report from The Denver Post analyzes the fallout of the post-pandemic cannabis industry in Colorado.  “The market’s just bad. It’s bad right now,” cannabis salesperson Val Tonazzi told The Denver Post. “There’s businesses closing, left and right.” Colorado Gov. Jared Polis recently sent a letter to President Joe Biden on Sept. 5 regarding the U.S. Department of Health and Human Services’ (HHS) recommendation for the Drug Enforcement Administration (DEA) to reschedule cannabis from a Schedule I substance to a Schedule III substance.  “We are pleased to hear that you have recently received Health and Human Services’s (HHS) recommendation to move cannabis to Schedule III,” Polis began in his letter. “It’s about time.” “This is an historic moment and we owe you and your administration a debt of gratitude for your leadership on catching up with where the science is,” Polis continued.  “Cannabis’ current classification under federal law as a Schedule I drug is contradicted by the scientific evidence. The notion, as previously considered, that cannabis has no accepted medical use, a high potential for abuse, and no accepted safety standards even under medical supervision has been widely disproven, HHS’s recommendation is evidence-based and a move in the right direction.” Polis also addresses the issues that still need to be resolved, such as banking. He wrote that if cannabis becomes a Schedule III substance, banks would be free to serve cannabis businesses and that tax code 280E would no longer be necessary. Oversupply, lack of demand, competition with neighboring legal states, and black market sales, puts Colorado cannabis businesses in a bind. 

https://hightimes.com/

Alabama Regulators Plan To Issue Medical Cannabis Licenses By Year’s End

The Alabama Medical Cannabis Commission (AMCC) hopes to issue licenses for medical marijuana cultivators and distributors by the end of 2023, officials with the agency said last week. The plan, which was approved by the commission on October 12, comes following multiple lawsuits were filed challenging the rollout of the state’s medical cannabis program. Alabama state lawmakers legalized the use of medical cannabis for patients with certain qualifying conditions in 2021. But nearly two and a half years later, cannabis is still not available for the patients who need it. The AMCC issued its first round of licenses in June of this year. But only four days later, the commission put a hold on the licenses and eventually rescinded them because of errors in tabulating applications. Licenses for the potentially lucrative permits were again issued on August 10, but lawsuits challenging the process were filed by unsuccessful applicants.  “There are claims alleging the scoring was deficient in various areas. We’ve had claims, speculating that the scoring is inconsistent for different reasons,” said Mark Wilkerson, an AMCC attorney. A judge issued a temporary restraining order in the case, and the licenses were put on hold once again. The restraining order still stands but could be lifted by the judge at a hearing later this week. A separate lawsuit from successful applicants challenging the commission’s decision to rescind the original licenses was dismissed by the judge in the case on October 11. One day later, the commission adopted an emergency rule to approve a new process for awarding the licenses that allows applicants to make a presentation to the agency. Commissioners will also consider the scores of previously submitted applications. With the new procedure in place, the AMCC hopes to begin issuing licenses by the end of the year. “It kind of is a reset,” commission chairman Rex Vaughn said after the end of the meeting, according to a report from the Associated Press. “We think we have a process to move forward, not ditching what we’ve already done, but making use of it as best as possible.” Attorney Will Somerville represents Alabama Always, a Montgomery company that was not awarded a license after investing $7 million in a cultivation facility. He said that the new process allowing the company to make a presentation to the commission is a positive development. “The commission should be evaluating people based on whether they are available to commence cultivation within 60 days after receiving a license and reaching full capacity,” Somerville told local media. “Most of the applicants who got awarded licenses, or five of them, aren’t able to do that.” Somerville added that the earlier licenses were awarded based on “how pretty is your application and not whether you can really do it,” and said that the new process “will allow us to explain why we can commence cultivation faster than anybody else.” The slow rollout of Alabama’s medical marijuana program has frustrated patients eager to take advantage of the medicinal benefits of cannabis. Amanda Taylor, 49, used to live in Arizona, where she used medical marijuana to treat multiple sclerosis. She said that medical cannabis can help ease spasms and pain caused by the disease, but it is still not available in Alabama. “It’s vital for patients like myself, who are suffering,” Taylor said. “It’s not about getting high. It’s about healing.” Alabama’s medical marijuana law allows patients with certain serious medical conditions including multiple sclerosis, autism, Crohn’s disease, certain cancers, depression and Parkinson’s disease, among others, to use cannabis medicinally. The AMCC chairman hopes the commission’s new licensing procedure will allow the agency to issue new licenses in 2023. “Our goal is to get to a have a victory lap by the end of the year,” said Vaughn. “Well, we’ll see how that goes. But it’s going to take a lot of work on the part of our commission members.”

FAQ: How to use this hemp news hub

What topics does Chow420’s hemp news cover?

We aggregate and surface reputable coverage on hemp laws and enforcement, THC thresholds and policy proposals, cannabinoid products (CBD/Delta-8/hemp-derived THC), compliance, lab testing, recalls, and broader industry news.

Is this legal advice?

No. This page is for news and education. Hemp rules can change quickly and vary by state—always verify against the latest official guidance and consult qualified counsel for compliance decisions.

How do I evaluate hemp product safety claims?

Look for current third‑party COAs (Certificates of Analysis), clear ingredient labeling, and transparent sourcing. Be cautious with vague potency claims or missing lab reports.

Why do some articles mention Delta‑8 or “hemp-derived THC”?

These products often sit at the center of policy and enforcement changes. We track major updates so shoppers and brands can understand evolving requirements and market impacts.

How often is the news updated?

The crawler is scheduled to run daily. New items appear as sources publish updates.